Literature DB >> 20819627

Ningbo thyroid dysfunction prevalence study: a cross-sectional survey in an employees-cohort.

Yu-Shan Mao1, Zhi-Min Liu, Chang-Xi Chen, Zhong-Wei Zhu, Zhong-Li Hong.   

Abstract

BACKGROUND: The prevalence and the spectrum of thyroid dysfunction in the mainland of China are not adequately understood. We performed a population-based study to determine the prevalence of major thyroid dysfunctions including overt and subclinical hyper- and hypothyroidism in a stable cohort.
METHODS: All active and retired employees aged 20 years and older (11 067) of Sinopec Zhenhai Refining & Chemical Company in Ningbo participated in the cross-sectional survey with a questionnaire and blood samples.
RESULTS: A total of 10 405 individuals attended for screening. Using biochemical definitions 95.5% were euthyroid. The prevalence of former diagnosed hyperthyroidism was 1.1% in females and 0.4% in males, hypothyroidism 1.7% and 0.3%, and thyroid surgery 1.2% and 0.3%, respectively. In both sex the prevalence increased with age. Twenty-four percent of individuals with thyroid surgery or medications had abnormal thyroid-stimulating hormone (TSH) levels. In individuals without a history of thyroid disease, the prevalence of pathological TSH values in females and males were TSH > or = 10 mU/L 0.60% and 0.29%; TSH 4.8-9.9 mU/L 5.71% and 2.25%; TSH < 0.3 mU/L 0.87% and 0.41%, respectively. Overt hyper- and hypothyroidism were uncommon (0.2%, 0.3%, respectively). The prevalence of subclinical hyper- and hypothyroidism was 0.4% and 3.4%, respectively. Subclinical hypothyroidism was more common in females (male 2.4% vs. female 5.8%, P < 0.001) and with increasing age (P < 0.001).
CONCLUSIONS: The prevalence of thyroid dysfunction is 4.5% in the cohort. Among individuals with thyroid medications or surgery, only 75.7% were within the normal range of TSH. These results indicate that thyroid dysfunction is common in Chinese adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819627

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees.

Authors:  Yu-Shan Mao; Yi-Feng Mai; Fu-Jun Li; Yan-Ming Zhang; Ke-Min Hu; Zhong-Li Hong; Zhong-Wei Zhu
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

2.  An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan.

Authors:  Tuanyu Fang; Leweihua Lin; Qianying Ou; Lu Lin; Huachuan Zhang; Kaining Chen; Huibiao Quan; Yangli He
Journal:  Int J Endocrinol       Date:  2022-07-09       Impact factor: 2.803

3.  Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.

Authors:  Z Yan; H Huang; J Li; J Wang
Journal:  Osteoporos Int       Date:  2015-07-30       Impact factor: 4.507

4.  Development and validation of a carotid atherosclerosis risk prediction model based on a Chinese population.

Authors:  Guoqing Huang; Qiankai Jin; Xiaoqing Tian; Yushan Mao
Journal:  Front Cardiovasc Med       Date:  2022-08-02

5.  Prognosis of thyroid nodules in individuals living in the Zhitomir region of Ukraine.

Authors:  Naomi Hayashida; Yui Sekitani; Jumpei Takahashi; Alexander A Kozlovsky; Oleksandr K Gutevych; Aleksey S Saiko; Nina V Nirova; Anjela A Petrova; Ruslan M Rafalskiy; Sergey A Chorny; Valery V Daniliuk; Masanobu Anami; Shunichi Yamashita; Noboru Takamura
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

6.  Effect of subclinical hypothyroidism on the skeletal system and improvement with short-term thyroxine therapy.

Authors:  Cuixia Gao; Yu Wang; Tingting Li; Jing Huang; Limin Tian
Journal:  Oncotarget       Date:  2017-07-26

7.  The association between subclinical hypothyroidism and erectile dysfunction.

Authors:  Dawei Chen; Yuerong Yan; Hui Huang; Qiang Dong; Haoming Tian
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.